[Future therapies for metabolic bone diseases. New concepts and targets].
Nemec
K
K
Institut für Pharmazeutische Chemie Marie-Curie-Str. 9 60439 Frankfurt. Schubert-Zsilavecz@pharmchem.uni-frankfurt.de
Schubert-Zsilavecz
M
M
D001851:Bone Diseases, Metabolic / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D006023:Glycoproteins / Q000235:genetics / Q000502:physiology*; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000502:physiology*; D018124:Receptors, Tumor Necrosis Factor
D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human